Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 252-899-6 | CAS number: 36177-92-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- For animal welfare reasons no new study (LLNA) was conducted. Instead existing data was obtained via the SIEF. Therefore the type of study could not be influenced by the registrant at this point.
- Species:
- guinea pig
- Strain:
- other: Crl:(HA)BR
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 6 weeks
- Weight at study initiation: 416-485 g
- Housing: individually
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18-26°C
- Humidity (%): 30-70%
- Photoperiod (hrs dark / hrs light): 12/12 - Route:
- intradermal and epicutaneous
- Vehicle:
- water
- Concentration / amount:
- 1. induction: intradermal injection: 0.1%
2. induction: topical application: 5%
3. challenge: topical application: 1.0% - Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- 1. induction: intradermal injection: 0.1%
2. induction: topical application: 5%
3. challenge: topical application: 1.0% - No. of animals per dose:
- 20 for the test group
10 for the control group - Details on study design:
- RANGE FINDING TESTS: In an irritation screening study, a subgroup of four male guinea pigs received 0.1mL intradermal injections of T-7 prepared at concentrations of 0.1, 1.0, 5, 10, and 25% w/v in sterile water (five test sites per animal). The test sites were evaluated for dermal reactions at 24 and 48 hours after injection. A second irritation screening subgroup of four animals first received duplicate 0.1mL intradermal injections of 1:1 Freund’s Complete Adjuvant (FCA) and sterile water on the shaved shoulder area (one injection on each side of the midline). Seven days after administration of the intradermal injections, the animals received a topical application of the test material at concentrations of 10, 25, 50 and 75% w/v in sterile water. Each animal received all four concentrations of the test material (four test sites per animal). All test sites were occluded for 24 hours. After treatment, all four animals exhibited severe dermal reactions at some of the sites and clinical signs of toxicity including hypoactivity, lacrimation, hypothermia, dyspnea, squinted eyes, and decreased feces. As a result of these observations, the animals were sacrificed in a moribund condition and 24 hour scores were not obtained. A third irritation screening subgroup of four animals first received duplicate 0.1mL intradermal injections of 1:1 Freund’s Complete Adjuvant (FCA) and sterile water on the shaved shoulder area (one injection on each side of the midline). Seven days after administration of the intradermal injections, the animals received a topical application of the test material at concentrations of 0.1, 0.5, 1.0 and 5.0% w/v in sterile water. Each animal received all four concentrations of the test material (four test sites per animal). All test sites were occluded for 24 hours and dermal irritation was evaluated at 24 and 48 hours after removal of the patches.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 inductions
- Exposure period: 1. intradermal injection 7 days, 2. topical application: 48 hours
- Test groups: 1 group received 1:1 dilution of FCA in sterile water or test substance diluted in water
- Control group: 1 group received 1:1 dilution of FCA in sterile water or water alone
- Site: intradermal injection: shoulder area: anterior sites, medial sites and posterior sites
- Frequency of applications: 3 intradermal injections, after seven days one topical application - Challenge controls:
- Induction: intradermal injection: anterior site: 1:1 dilution of FCA in sterile water; medial site: sterile water; posterior site: 1:1 dilution of FCA in sterile water
Induction: topical application: sterile water - Positive control substance(s):
- yes
- Remarks:
- alpha-hexylcinnamaldehyde
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 1.0%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 1.0%. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1.0%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 1.0%. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 1.0%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 1.0%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 1.0%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 1.0%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 50%
- No. with + reactions:
- 8
- Total no. in group:
- 9
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: positive control. Dose level: 50%. No with. + reactions: 8.0. Total no. in groups: 9.0.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 50%
- No. with + reactions:
- 5
- Total no. in group:
- 9
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: positive control. Dose level: 50%. No with. + reactions: 5.0. Total no. in groups: 9.0.
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Migrated information
- Conclusions:
- Based on the results of this study the test item is not considered to be a dermal sensitizer.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The skin sensitizing potential of the substance was investigated in a Guinea Pig Maximization Test.
Based on the results of an irritation screening study the test item was administered as 0.1% (w/v) mixture in sterile water and in 1:1 FCA/sterile water for the intradermal injection phase, as a 5% (m/v) mixture in sterile water for the topical induction phase, and as a 1% mixture for the challenge application phase in the definitive study. Twenty animals were assigned to the test group and 10 animals were assigned to the irritation control group (negative control).
None of the animals in the test or the irritation control group exhibited a dermal reaction to the challenge application of the test material.
Therefore, based on the outcome of the available Guinea Pig Maximization Test, the substance is not considered to be a skin sensitizer.
Migrated from Short description of key information:
No sensitizing potential could be induced with the test substance in a Guinea Pig (modified) maximization test.
Justification for selection of skin sensitisation endpoint:
There is one valid GLP guideline study available.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
- Migrated from Short description of key information:
For the endpoint respiratory sensitization no study is available.
Justification for selection of respiratory sensitisation endpoint:
Data are conclusive but not sufficient for classification of the test substance with regard to skin sensitization in accordance to the CLP Regulation (EC) No 1272/2008.
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
